Vivos Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Vivos Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q3 2024.
  • Vivos Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 78.6 %, a 11.3% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 78.6 +7.98 +11.3% Sep 30, 2024
Q2 2024 54.5 -45.4 -45.4% Jun 30, 2024
Q1 2024 43.3 -100 -69.8% Mar 31, 2024
Q4 2023 59.9 -143 -70.4% Dec 31, 2023
Q3 2023 70.6 -210 -74.8% Sep 30, 2023
Q2 2023 100 -243 -70.9% Jun 30, 2023
Q1 2023 143 -247 -63.3% Mar 31, 2023
Q4 2022 203 -161 -44.2% Dec 31, 2022
Q3 2022 280 -58.4 -17.3% Sep 30, 2022
Q2 2022 343 Jun 30, 2022
Q1 2022 391 Mar 31, 2022
Q4 2021 364 Dec 31, 2021
Q3 2021 339 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.